ABIN2 function is required to suppress DSS-induced colitis by a Tpl2-independent mechanism

Nanda, S. K., Nagamori, T., Windheim, M., Amu, S., Aviello, G., Patterson-Kane, J., Arthur, J. S. C., Ley, S. C., Fallon, P. and Cohen, P. (2018) ABIN2 function is required to suppress DSS-induced colitis by a Tpl2-independent mechanism. Journal of Immunology, 201(11), pp. 3373-3382. (doi: 10.4049/jimmunol.1700614) (PMID:30355787)

Full text not currently available from Enlighten.

Abstract

The A20-binding inhibitor of NF-κB 2 (ABIN2) interacts with Met1-linked ubiquitin chains and is an integral component of the tumor progression locus 2 (Tpl2) kinase complex. We generated a knock-in mouse expressing the ubiquitin-binding-defective mutant ABIN2[D310N]. The expression of Tpl2 and its activation by TLR agonists in macrophages or by IL-1β in fibroblasts from these mice was unimpaired, indicating that the interaction of ABIN2 with ubiquitin oligomers is not required for the stability or activation of Tpl2. The ABIN2[D310N] mice displayed intestinal inflammation and hypersensitivity to dextran sodium sulfate-induced colitis, an effect that was mediated by radiation-resistant cells rather than by hematopioetic cells. The IL-1β-dependent induction of cyclooxygenase 2 (COX2) and the secretion of PGE was reduced in mouse embryonic fibroblasts and intestinal myofibroblasts (IMFs) from ABIN2[D310N] mice. These observations are similar to those reported for the Tpl2 knockout (KO) mice (Roulis et al. 2014. 111: E4658-E4667), but the IL-1β-dependent production of COX2 and PGE in mouse embryonic fibroblasts or IMFs was unaffected by pharmacological inhibition of Tpl2 in wild-type mice. The expression of ABIN2 is decreased drastically in Tpl2 KO mice. These and other lines of evidence suggest that the hypersensitivity of Tpl2 KO mice to dextran sodium sulfate-induced colitis is not caused by the loss of Tpl2 catalytic activity but by the loss of ABIN2, which impairs COX2 and PGE production in IMFs by a Tpl2 kinase-independent pathway.

Item Type:Articles
Additional Information:This work was supported by the U.K. Medical Research Council (Grant MRC_MR/ K000985/1), Boehringer-Ingelheim, GlaxoSmithKline, and Merck Serono. T.N. was funded by the Uehara Memorial Foundation for International Students (Grant 201440246). S.C.L. is supported by core funding from The Francis Crick Institute.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Patterson-Kane, Professor Janet
Authors: Nanda, S. K., Nagamori, T., Windheim, M., Amu, S., Aviello, G., Patterson-Kane, J., Arthur, J. S. C., Ley, S. C., Fallon, P., and Cohen, P.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Journal of Immunology
Publisher:American Association of Immunologists
ISSN:0022-1767
ISSN (Online):1550-6606
Published Online:24 October 2018

University Staff: Request a correction | Enlighten Editors: Update this record